Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA: 600436)
China
· Delayed Price · Currency is CNY
205.50
-3.56 (-1.70%)
Jan 3, 2025, 3:00 PM CST
Zhangzhou Pientzehuang Pharmaceutical., Revenue
Zhangzhou Pientzehuang Pharmaceutical., had revenue of 2.80B CNY in the quarter ending September 30, 2024, with 9.60% growth. This brings the company's revenue in the last twelve months to 10.91B, up 12.72% year-over-year. In the year 2023, Zhangzhou Pientzehuang Pharmaceutical., had annual revenue of 10.06B with 15.69% growth.
Revenue (ttm)
10.91B
Revenue Growth
+12.72%
P/S Ratio
11.37
Revenue / Employee
3.91M
Employees
2,789
Market Cap
123.98B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 10.06B | 1.36B | 15.69% |
Dec 31, 2022 | 8.69B | 672.45M | 8.38% |
Dec 31, 2021 | 8.02B | 1.51B | 23.20% |
Dec 31, 2020 | 6.51B | 788.51M | 13.78% |
Dec 31, 2019 | 5.72B | 956.12M | 20.06% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
Jiangsu Hengrui Medicine | 26.00B |
WuXi AppTec | 38.50B |
Aier Eye Hospital Group | 20.62B |
Shanghai United Imaging Healthcare | 10.93B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Beijing Wantai Biological Pharmacy Enterprise | 2.49B |
Sichuan Biokin Pharmaceutical Co.,Ltd. | 5.85B |